MICHAEL HORSEMAN: Open Payments
NPI 1245297993 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 79 payments from 16 companies in 2025. Trend: 2023 $2,181 · 2024 $1,919 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $315 |
| PFIZER INC. | 15 | $289 |
| Novo Nordisk Inc | 12 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $147 |
| Lilly USA, LLC | 5 | $103 |
| Astellas Pharma US Inc | 4 | $102 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Exact Sciences Corporation | 2 | $51 |
| Abbott Laboratories | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $23 |
Products named: VRAYLAR, NURTEC ODT, JARDIANCE, Rybelsus, Veozah, MOUNJARO, Ozempic, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
